Table 2.
All Patients | Clade 1 | Clade 2 | P Value⁎ | |
---|---|---|---|---|
All | 24 | 9 | 15 | |
Age at diagnosis | ||||
Median (mean) | 55.5 (55) | 57 (59.9) | 52 (52.1) | .16 |
Range | 26-73 | 53-73 | 26-72 | |
FIGO stage | ||||
I | 14 (58%) | 4 (44%) | 10 (67%) | .40 |
II/III/IV | 10 (42%) | 5 (56%) | 5 (33%) | |
Grade | ||||
Low | 2 (8%) | 0 (0%) | 2 (13%) | .51 |
High | 22 (92%) | 9 (100%) | 13 (87%) | |
Size | ||||
≤ 10 cm | 13 (54%) | 4 (44%) | 9 (60%) | .68 |
> 10 cm | 11 (46%) | 5 (56%) | 6 (40%) | |
Mitotic index (five missing) | ||||
≤ 20 | 13 (68%) | 4 (67%) | 9 (69%) | 1 |
> 20 | 6 (32%) | 2 (33%) | 4 (31%) | |
Adjuvant therapy | ||||
No | 17 (71%) | 6 (67%) | 11 (73%) | 1 |
Yes | 7 (29%) | 3 (33%) | 4 (27%) |
P values were obtained by using Wilcoxon-Rank Sum test for “age at diagnosis” and Fisher's exact test for the other variables.